Abstract
Extremely low frequency electromagnetic radiation (ELF-EMR) is an omnipresent component of electricity, with a frequency of 3-30Hz, and wavelengths 3,450-5,996km long. We reviewed the scientific literature regarding pediatric health effects resulting from chronic exposure to ELF-EMR and compared these with the international safety standards. Articles published between 1980-2007 were identified using Medline, Cancerlite, Science Citation Index, and EMBASE. For the general population, the International Commission on Non-Ionizing Radiation Protection considers chronic exposure to magnetic fields lower than 100μT to be safe. However, even 0.3-0.4μT has been associated with an increased risk of acute lymphoblastic leukemia (ALL) in children. Although there is no experimental model to test the effects of ELF-EMR on organic systems, the Precautionary Principle is fundamental to the protection of children who are exposed to residential radiation doses higher than 0.3μT.
Keywords: Children, environmental risk, policies, electromagnetic fields, power lines
Current Pediatric Reviews
Title: Pediatric Health Effects of Chronic Exposure to Extremely Low Frequency Electromagnetic Fields
Volume: 5 Issue: 4
Author(s): Juan Antonio Ortega-Garcia, Marlene Martin, Enrique Navarro-Camba, Julia Garcia-Castell, Offie P. Soldin and Josep Ferris-Tortajada
Affiliation:
Keywords: Children, environmental risk, policies, electromagnetic fields, power lines
Abstract: Extremely low frequency electromagnetic radiation (ELF-EMR) is an omnipresent component of electricity, with a frequency of 3-30Hz, and wavelengths 3,450-5,996km long. We reviewed the scientific literature regarding pediatric health effects resulting from chronic exposure to ELF-EMR and compared these with the international safety standards. Articles published between 1980-2007 were identified using Medline, Cancerlite, Science Citation Index, and EMBASE. For the general population, the International Commission on Non-Ionizing Radiation Protection considers chronic exposure to magnetic fields lower than 100μT to be safe. However, even 0.3-0.4μT has been associated with an increased risk of acute lymphoblastic leukemia (ALL) in children. Although there is no experimental model to test the effects of ELF-EMR on organic systems, the Precautionary Principle is fundamental to the protection of children who are exposed to residential radiation doses higher than 0.3μT.
Export Options
About this article
Cite this article as:
Antonio Ortega-Garcia Juan, Martin Marlene, Navarro-Camba Enrique, Garcia-Castell Julia, P. Soldin Offie and Ferris-Tortajada Josep, Pediatric Health Effects of Chronic Exposure to Extremely Low Frequency Electromagnetic Fields, Current Pediatric Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339609791317333
DOI https://dx.doi.org/10.2174/157339609791317333 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Utility of Assessing Thiopurine S-methyltransferase Polymorphisms Before Azathioprine Therapy
Current Drug Metabolism Advanced Techniques for Penetration Enhancement in Transdermal Drug Delivery System
Current Drug Delivery Assessing Combinations of Cytotoxic Agents Using Leukemia Cell Lines
Current Drug Targets Papillary Thyroid Carcinoma in Pediatric Age: An Example of a Rare Tumour Managed Within a Cooperative Comprehensive Project
Current Pediatric Reviews Gender Differences in Metabolic Syndrome – A Key Research Issue
Endocrine, Metabolic & Immune Disorders - Drug Targets How to Manage the Infectious Risk under Anti-TNF in Inflammatory Bowel Disease
Current Drug Targets Cytokines in the Pathogenesis of Chronic Obstructive Pulmonary Disease
Current Pharmaceutical Design Adiponectin in Asthma: Implications for Phenotyping
Current Protein & Peptide Science Treatment of Atopic Dermatitis: Current Status and Future Prospects
Current Drug Therapy The CXCL12/CXCR4 Axis as a Therapeutic Target in Cancer and HIV-1 Infection
Current Medicinal Chemistry GABA Puts a Stop to Pain
Current Drug Targets - CNS & Neurological Disorders A Scientific Approach to Anti-Ageing Therapies: State of the Art
Current Pharmaceutical Design Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment
Mini-Reviews in Medicinal Chemistry Headache: One of the Most Common and Troublesome Adverse Reactions to Drugs
Current Drug Safety Animal Models for the Evaluation of Theranostic Radiopharmaceuticals
Current Radiopharmaceuticals Family Psychoeducation in Clinical High Risk and First-Episode Psychosis
Adolescent Psychiatry Inflammatory Mediators in Epilepsy
Current Pharmaceutical Design Pulmonary Embolism and Pregnancy
Current Women`s Health Reviews Common Variants for Heart Failure
Current Genomics New Pharmacological Approaches in Infants with Hypoxic-Ischemic Encephalopathy
Current Pharmaceutical Design